INSP Inspire Medical Systems

Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference

Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference

MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2025 UBS Global Healthcare Conference on Monday, November 10, 2025.

Inspire is scheduled to present at 11:45 a.m. Eastern Time. The presentation will be accessible via a live webcast .

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at .

About Inspire Medical Systems

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit .

Investor and Media Contact

Ezgi Yagci

Vice President, Investor Relations



617-549-2443



EN
27/10/2025

Underlying

INSPInspire Medical Systems

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inspire Medical Systems

 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2...

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Ins...

January 7, 2026 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morga...

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible vi...

December 29, 2025 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Ann...

Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025. Inspire is scheduled to present at 11:30 a.m. Eastern Time. The presentation will be accessib...

November 18, 2025 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial R...

Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2025. Recent Business Highlights Generated revenue of $224.5 million in the third quarter of 2025, a 10% increase over the same quarter last...

November 3, 2025 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Health...

Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2025 UBS Global Healthcare Conference on Monday, November 10, 2025. Inspire is scheduled to present at 11:45 a.m. Eastern Time. The presentation will be accessible via a live webcas...

October 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch